Concepedia

Kristine C. Federico

KC

Statistics

Publications

2

Citations

181

H-Index

2

Active since

2010

Affiliations

Supernus Pharmaceuticals (United States)(Current)

Kristine C. Federico is an author at Supernus Pharmaceuticals (United States) specializing in medicine, angiogenesis, and pharmacology.

Publications per year

2010–2011

2

Publications

2

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas

Monica Mita, Matthew A. Spear, Lorrin Yee et al. · Clinical Cancer Research · 2010 · 107 citations

, , +16

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Michael Millward, Paul N. Mainwaring, Alain C. Mita et al. · Investigational New Drugs · 2011 · 74 citations

, , +5

1–2 of 2